Touchstone International Medical Science Co., Ltd. (SHA:688013)
China
· Delayed Price · Currency is CNY 41.68
+1.81 (4.54%)
Mar 10, 2026, 3:00 PM CST
SHA:688013 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Operating Revenue | 326.74 | 272.34 | 253.6 | 231.73 | 213.74 | Upgrade
|
| Other Revenue | - | 0.03 | 0.04 | 0.31 | 0 | Upgrade
|
| Revenue | 326.74 | 272.37 | 253.65 | 232.03 | 213.74 | Upgrade
|
| Revenue Growth (YoY) | 19.96% | 7.38% | 9.31% | 8.56% | 30.85% | Upgrade
|
| Cost of Revenue | - | 113.64 | 111.8 | 99.8 | 91.27 | Upgrade
|
| Gross Profit | 326.74 | 158.73 | 141.85 | 132.23 | 122.47 | Upgrade
|
| Selling, General & Admin | - | 74.66 | 71.9 | 61.66 | 62.37 | Upgrade
|
| Research & Development | - | 35.99 | 35.32 | 34.75 | 29.28 | Upgrade
|
| Other Operating Expenses | 232.5 | 1.79 | 4.75 | 2.39 | 2.13 | Upgrade
|
| Operating Expenses | 232.5 | 112.38 | 112.27 | 98.97 | 94.05 | Upgrade
|
| Operating Income | 94.24 | 46.34 | 29.58 | 33.27 | 28.41 | Upgrade
|
| Interest Expense | - | -0.23 | -0.09 | -0.16 | - | Upgrade
|
| Interest & Investment Income | - | 9.12 | 8.03 | 4.76 | 11.15 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.01 | 2.47 | 3.94 | 4 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.45 | -0.17 | 1.89 | -0.12 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | 93.79 | 55.06 | 41.88 | 41.69 | 43.51 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -1.89 | 4.06 | 2.09 | 0.44 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0 | 0 | 0.02 | 0.52 | Upgrade
|
| Legal Settlements | - | - | - | - | -1.08 | Upgrade
|
| Other Unusual Items | - | 1.66 | 2.01 | 2.28 | 2.71 | Upgrade
|
| Pretax Income | 93.79 | 54.83 | 47.95 | 46.08 | 46.09 | Upgrade
|
| Income Tax Expense | 9.7 | 2.94 | 0.64 | 2.89 | 4.67 | Upgrade
|
| Net Income | 84.09 | 51.89 | 47.31 | 43.2 | 41.42 | Upgrade
|
| Net Income to Common | 84.09 | 51.89 | 47.31 | 43.2 | 41.42 | Upgrade
|
| Net Income Growth | 62.04% | 9.69% | 9.53% | 4.29% | 18.52% | Upgrade
|
| Shares Outstanding (Basic) | 80 | 80 | 79 | 80 | 80 | Upgrade
|
| Shares Outstanding (Diluted) | 80 | 81 | 82 | 82 | 81 | Upgrade
|
| Shares Change (YoY) | -1.23% | -0.60% | 0.09% | 0.35% | 25.49% | Upgrade
|
| EPS (Basic) | 1.05 | 0.65 | 0.60 | 0.54 | 0.52 | Upgrade
|
| EPS (Diluted) | 1.05 | 0.64 | 0.58 | 0.53 | 0.51 | Upgrade
|
| EPS Growth | 64.06% | 10.35% | 9.43% | 3.92% | -5.56% | Upgrade
|
| Free Cash Flow | - | 11.47 | 64.54 | 2.73 | 51.77 | Upgrade
|
| Free Cash Flow Per Share | - | 0.14 | 0.79 | 0.03 | 0.64 | Upgrade
|
| Dividend Per Share | - | 1.000 | - | 0.250 | 0.200 | Upgrade
|
| Dividend Growth | - | - | - | 25.00% | - | Upgrade
|
| Gross Margin | 100.00% | 58.28% | 55.92% | 56.99% | 57.30% | Upgrade
|
| Operating Margin | 28.84% | 17.02% | 11.66% | 14.34% | 13.29% | Upgrade
|
| Profit Margin | 25.74% | 19.05% | 18.65% | 18.62% | 19.38% | Upgrade
|
| Free Cash Flow Margin | - | 4.21% | 25.44% | 1.18% | 24.22% | Upgrade
|
| EBITDA | 103.43 | 55.53 | 38.63 | 41.35 | 35.64 | Upgrade
|
| EBITDA Margin | 31.65% | 20.39% | 15.23% | 17.82% | 16.67% | Upgrade
|
| D&A For EBITDA | 9.19 | 9.19 | 9.05 | 8.09 | 7.22 | Upgrade
|
| EBIT | 94.24 | 46.34 | 29.58 | 33.27 | 28.41 | Upgrade
|
| EBIT Margin | 28.84% | 17.02% | 11.66% | 14.34% | 13.29% | Upgrade
|
| Effective Tax Rate | 10.34% | 5.36% | 1.33% | 6.27% | 10.14% | Upgrade
|
| Revenue as Reported | - | 272.37 | 253.65 | 232.03 | 213.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.